Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy of autologous tumor lysate-pulsed dendritic and cytokine-induced killer cells (DC-CIK) for colorectal cancer (CRC).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shenzhen Hornetcorn Bio-technology Company, LTD
Collaborators
NCT07287098 · Breast Neoplasms
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07066046 · Colorectal Cancer (CRC), Adenomatous Polyposis, and more
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT07162337 · Colorectal Cancer Prevention, Colorectal Adenoma
Jingzhou Central Hospital Immunotherapy center
Jingzhou, Hubei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions